• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有唐氏综合征退行性障碍的年轻成年人对电休克治疗的临床反应

Clinical Response to Electroconvulsive Therapy in a Young Adult With Down Syndrome Regression Disorder.

作者信息

Kelley Brendan J, Bailey Kala J, Hubregsen Joshua J

机构信息

From the Departments of Neurology.

Psychiatry, University of Texas Southwestern, Dallas, TX.

出版信息

J ECT. 2025 Jun 1;41(2):e18-e20. doi: 10.1097/YCT.0000000000001093. Epub 2024 Dec 3.

DOI:10.1097/YCT.0000000000001093
PMID:39652068
Abstract

Down syndrome regression disorder (DSRD) is a condition in which individuals with Down syndrome experience a decline in social and adaptive functioning in adolescence to early adulthood. Initially described as catatonic psychosis and later designated Down syndrome disintegrative disorder (DSDD), the etiology for DSRD remains unclear but has been hypothesized to relate to autoimmune function, stress, and psychiatric disease. DSRD presents heterogeneously and has no clearly established diagnostic criteria, which can complicate treatment recommendations. ECT has been used to successfully treat DSRD, but the number of reported cases remains low, especially when it is unclear whether there are comorbid catatonic features. Here, we present a case of successful use of ECT in an individual with DSRD in which catatonic features were difficult to ascertain, and we make recommendations for the use of ECT in the treatment of DSRD.

摘要

唐氏综合征退行性障碍(DSRD)是一种唐氏综合征患者在青春期至成年早期社会和适应功能出现衰退的病症。最初被描述为紧张性精神病,后来被命名为唐氏综合征解体性障碍(DSDD),DSRD的病因尚不清楚,但据推测与自身免疫功能、压力和精神疾病有关。DSRD表现各异,且没有明确确立的诊断标准,这可能使治疗建议变得复杂。电休克治疗(ECT)已成功用于治疗DSRD,但报告的病例数量仍然较少,尤其是在难以确定是否存在共病的紧张性特征时。在此,我们介绍一例成功使用ECT治疗DSRD患者的病例,该患者的紧张性特征难以确定,并对ECT在DSRD治疗中的应用提出建议。

相似文献

1
Clinical Response to Electroconvulsive Therapy in a Young Adult With Down Syndrome Regression Disorder.一名患有唐氏综合征退行性障碍的年轻成年人对电休克治疗的临床反应
J ECT. 2025 Jun 1;41(2):e18-e20. doi: 10.1097/YCT.0000000000001093. Epub 2024 Dec 3.
2
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.抗精神病药治疗伴有紧张症症状的精神分裂症谱系障碍。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD013100. doi: 10.1002/14651858.CD013100.pub2.
3
Electroconvulsive therapy for schizophrenia.精神分裂症的电休克治疗
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000076. doi: 10.1002/14651858.CD000076.pub2.
4
A systematic review of modified electroconvulsive therapy (ECT) to treat delirium.一项关于改良电休克疗法(ECT)治疗谵妄的系统评价。
Acta Psychiatr Scand. 2023 May;147(5):403-419. doi: 10.1111/acps.13492. Epub 2022 Sep 15.
5
Electroconvulsive therapy for schizophrenia.精神分裂症的电休克治疗
Cochrane Database Syst Rev. 2002(2):CD000076. doi: 10.1002/14651858.CD000076.
6
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.预防囊性纤维化患者远端肠梗阻综合征(DIOS)的干预措施。
Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD012619. doi: 10.1002/14651858.CD012619.pub2.
9
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.预防囊性纤维化远端肠道梗阻综合征(DIOS)的干预措施。
Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD012619. doi: 10.1002/14651858.CD012619.pub3.
10
Brexanolone, zuranolone and related neurosteroid GABA receptor positive allosteric modulators for postnatal depression.用于产后抑郁症的布雷沙诺龙、祖拉诺龙及相关神经甾体GABA受体正变构调节剂。
Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2.